U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
JNJ-2463
Preferred Name English
NIMACIMAB
INN   USAN  
Official Name English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CANNABINOID RECEPTOR 1)HUMANIZED MONOCLONAL ANTIBODY: .GAMMA.4 HEAVY CHAIN (1-444) (HOMO SAPIENS VH (IGHV1-69*08 (88%) (IGHD)-IGHJ3*01 (91%)) (8.8.10) (1-107)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(225))) (108-444)
Systematic Name English
NIMACIMAB [USAN]
Common Name English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CNR1 (CANNABINOID RECEPTOR 1, CANN6, CNR)), HUMANIZED MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN HUMANIZED (1-444) (VH (HOMO SAPIENS IGHV1-69*02 (86.7%)-(IGHD)-IGHJ4*01 (90.9%)) (8.8.10) (1-117)-HOMO SAPIENS IGHG4*0
Systematic Name English
RYI-018
Code English
IMMUNOGLOBULIN G4 (228-PROLINE), ANTI-(HUMAN CANNABINOID RECEPTOR 1) (HUMAN-MUS MUSCULUS MONOCLONAL RYI-018 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RYI-018 .KAPPA.-CHAIN, DIMER
Systematic Name English
JNJ2463
Code English
RYI018
Code English
nimacimab [INN]
Common Name English
Code System Code Type Description
USAN
FG-02
Created by admin on Tue Apr 01 22:47:02 GMT 2025 , Edited by admin on Tue Apr 01 22:47:02 GMT 2025
PRIMARY
NCI_THESAURUS
C175163
Created by admin on Tue Apr 01 22:47:02 GMT 2025 , Edited by admin on Tue Apr 01 22:47:02 GMT 2025
PRIMARY
CAS
2098636-09-8
Created by admin on Tue Apr 01 22:47:02 GMT 2025 , Edited by admin on Tue Apr 01 22:47:02 GMT 2025
PRIMARY
INN
11023
Created by admin on Tue Apr 01 22:47:02 GMT 2025 , Edited by admin on Tue Apr 01 22:47:02 GMT 2025
PRIMARY
DRUG BANK
DB15115
Created by admin on Tue Apr 01 22:47:02 GMT 2025 , Edited by admin on Tue Apr 01 22:47:02 GMT 2025
PRIMARY
SMS_ID
300000005902
Created by admin on Tue Apr 01 22:47:02 GMT 2025 , Edited by admin on Tue Apr 01 22:47:02 GMT 2025
PRIMARY
FDA UNII
85TS31SOL3
Created by admin on Tue Apr 01 22:47:02 GMT 2025 , Edited by admin on Tue Apr 01 22:47:02 GMT 2025
PRIMARY
ACTIVE MOIETY
NIMACIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966